R-Biopharm Neugen Private Limited

Marketing and distributing diagnostic kits and instruments for international companies in India.

1997 | Hyderabad, Telangana (India) | Active
Last Updated:

R-Biopharm Neugen Profile

Key Indicators

  • Authorised Capital ₹ 8.00 M
  • Paid Up Capital ₹ 7.83 M
  • Company Age 27 Year, 11 Months
  • Last Filing with ROC 31 Dec 2023
  • Open Charges ₹ 1.19 Cr
  • Revenue Growth -16.07%
  • Profit Growth 124.90%
  • Ebitda -22.93%
  • Net Worth 3.65%
  • Total Assets -16.05%

About R-Biopharm Neugen

R-Biopharm Neugen Private Limited (RNPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 May 1997 and has a history of 27 years and 11 months. Its registered office is in Hyderabad, Telangana, India.

The Corporate was formerly known as Harmony Hi-Tech (Madras) Private Limited. The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 December 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 7.83 M.

The company currently has active open charges totaling ₹1.19 Cr.

Christian Dreher and Shivani Desai serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74220TG1997PTC098579

  • Company No.

    098579

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    21 May 1997

  • Date of AGM

    21 Jun 2024

  • Date of Balance Sheet

    31 Dec 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Healthcare
Chemicals and Materials

What products or services does R-Biopharm Neugen Private Limited offer?

R-Biopharm Neugen Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Medical Consultancy Services, Medical Surgery & Treatment Centres, Medical Treatment Services, Material Testing Labs & Services, Testing Services.

Company report

R-Biopharm Neugen Private Limited

Explore comprehensive data for R-Biopharm Neugen Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at R-Biopharm Neugen?

Board Members (2)

NameDesignationAppointment DateStatus
Shivani Desai Country flag representing In Director 04-Mar-2021Current
Christian Dreher Country flag representing De Director 24-Oct-2013Current

Financial Performance of R-Biopharm Neugen.

R-Biopharm Neugen Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 16.07% decrease. The company also saw a substantial improvement in profitability, with a 124.9% increase in profit. The company's net worth moved up by a moderate rise of 3.65%.

R-Biopharm Neugen revenue growth over time
R-Biopharm Neugen profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-16.07%
Revenue from Operations
-11.03%
Total Assets
-16.05%
Profit or Loss
124.90%
Net Worth
3.65%
EBITDA
-22.93%

What is the Ownership and Shareholding Structure of R-Biopharm Neugen?

In 2022, R-Biopharm Neugen had a promoter holding of 100.00%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹11.92 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Corporate Bank : 1.09 Cr
  • Others : 0.10 Cr

Latest Charge Details

DateLenderAmountStatus
04 May 2020Others₹1.00 MOpen
18 Oct 2012Corporate Bank₹1.09 CrOpen

How Many Employees Work at R-Biopharm Neugen?

R-Biopharm Neugen has a workforce of 26 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for R-Biopharm Neugen Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of R-Biopharm Neugen, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R-Biopharm Neugen's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on R-Biopharm Neugen

Recent activity within the organization

  • Annual General Meeting

    R-Biopharm Neugen Private Limited last Annual general meeting of members was held on 21 Jun 2024 as per latest MCA records.

  • Balance Sheet

    R-Biopharm Neugen Private Limited has filed its annual Financial statements for the year ended 31 Dec 2023 with Roc Hyderabad.

  • Director Appointment

    Shivani Bhadresh Desai was appointed as a Director was appointed as a Director on 04 Mar 2021 & has been associated with this company since 4 years 2 months .

  • Charges

    A charge with Others amounted to Rs. 1.00 M with Charge ID 100405168 was registered on 04 May 2020.

  • Director Appointment

    Christian Moraeno Dreher was appointed as a Director was appointed as a Director on 24 Oct 2013 & has been associated with this company since 11 years 6 months .

  • Charges

    A charge with Corporate Bank amounted to Rs. 10.92 M with Charge ID 10385300 was registered on 18 Oct 2012.

Frequently asked questions

  • What is the Incorporation or founding date of R-Biopharm Neugen Private Limited?

    R-Biopharm Neugen Private Limited was incorporated on 21 May 1997.

  • What is authorized share capital and paid-up capital of R-Biopharm Neugen Private Limited?

    The authorized share capital of R-Biopharm Neugen Private Limited is ₹ 8.00 M and paid-up capital is ₹ 7.83 M.

  • Who are the current board members & directors of R-Biopharm Neugen Private Limited?

    Currently 2 directors are associated with R-Biopharm Neugen Private Limited.

    • Christian Moraeno Dreher
    • Shivani Bhadresh Desai

  • What is the registered address of R-Biopharm Neugen Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of R-Biopharm Neugen Private Limited is First Floor Plot No.70/ Part 71 Road No 3 Ida Phase I, Cherlapally India, Hyderabad, Telangana, 500051.

  • What is the corporate identification number (CIN) and company number of R-Biopharm Neugen Private Limited?

    The corporate identification number (CIN) of R-Biopharm Neugen Private Limited is U74220TG1997PTC098579 and the company number is 098579 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of R-Biopharm Neugen Private Limited?

    The Official website of R-Biopharm Neugen Private Limited is https://www.r-biopharm.com

  • What has been the recent revenue trend for R-Biopharm Neugen Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for R-Biopharm Neugen Private Limited has fallen by -16.07%.

  • How many employees does R-Biopharm Neugen Private Limited currently have?

    As Per 2022 financial reports, 26 employees are currently employed by R-Biopharm Neugen Private Limited.

  • What change has been observed in the net worth of R-Biopharm Neugen Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of R-Biopharm Neugen Private Limited has experienced an upsurge of 3.65%.

  • What are the total open charges for R-Biopharm Neugen Private Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for R-Biopharm Neugen Private Limited amount to ₹ 1.19 Cr.

  • When was the last Balance Sheet of R-Biopharm Neugen Private Limited filed with the ROC?

    The most recent Balance Sheet for R-Biopharm Neugen Private Limited was filed with the ROC on 31 Dec 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Chemical Distribution & Retail